These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
327 related articles for article (PubMed ID: 26965310)
1. Role of docosahexaenoic acid in the modulation of glial cells in Alzheimer's disease. Heras-Sandoval D; Pedraza-Chaverri J; Pérez-Rojas JM J Neuroinflammation; 2016 Mar; 13(1):61. PubMed ID: 26965310 [TBL] [Abstract][Full Text] [Related]
2. Long-chain polyunsaturated fatty acids (LCPUFA) from genesis to senescence: the influence of LCPUFA on neural development, aging, and neurodegeneration. Janssen CI; Kiliaan AJ Prog Lipid Res; 2014 Jan; 53():1-17. PubMed ID: 24334113 [TBL] [Abstract][Full Text] [Related]
5. Docosanoids and elovanoids from omega-3 fatty acids are pro-homeostatic modulators of inflammatory responses, cell damage and neuroprotection. Bazan NG Mol Aspects Med; 2018 Dec; 64():18-33. PubMed ID: 30244005 [TBL] [Abstract][Full Text] [Related]
6. Membrane lipid modifications and therapeutic effects mediated by hydroxydocosahexaenoic acid on Alzheimer's disease. Torres M; Price SL; Fiol-Deroque MA; Marcilla-Etxenike A; Ahyayauch H; Barceló-Coblijn G; Terés S; Katsouri L; Ordinas M; López DJ; Ibarguren M; Goñi FM; Busquets X; Vitorica J; Sastre M; Escribá PV Biochim Biophys Acta; 2014 Jun; 1838(6):1680-92. PubMed ID: 24374316 [TBL] [Abstract][Full Text] [Related]
7. Omega-3 Fatty Acid-Type Docosahexaenoic Acid Protects against Aβ-Mediated Mitochondrial Deficits and Pathomechanisms in Alzheimer's Disease-Related Animal Model. Park YH; Shin SJ; Kim HS; Hong SB; Kim S; Nam Y; Kim JJ; Lim K; Kim JS; Kim JI; Jeon SG; Moon M Int J Mol Sci; 2020 May; 21(11):. PubMed ID: 32486013 [TBL] [Abstract][Full Text] [Related]
9. Docosahexaenoic acid protects from amyloid and dendritic pathology in an Alzheimer's disease mouse model. Cole GM; Frautschy SA Nutr Health; 2006; 18(3):249-59. PubMed ID: 17180870 [TBL] [Abstract][Full Text] [Related]
10. Docosahexaenoic acid reduces amyloid-β induced toxicity in cells of the neurovascular unit. Veszelka S; Tóth AE; Walter FR; Datki Z; Mózes E; Fülöp L; Bozsó Z; Hellinger E; Vastag M; Orsolits B; Környei Z; Penke B; Deli MA J Alzheimers Dis; 2013; 36(3):487-501. PubMed ID: 23645098 [TBL] [Abstract][Full Text] [Related]
11. Cellular and molecular events mediated by docosahexaenoic acid-derived neuroprotectin D1 signaling in photoreceptor cell survival and brain protection. Bazan NG Prostaglandins Leukot Essent Fatty Acids; 2009; 81(2-3):205-11. PubMed ID: 19520558 [TBL] [Abstract][Full Text] [Related]
12. The binding of Aβ1-42 to lipid rafts of RBC is enhanced by dietary docosahexaenoic acid in rats: Implicates to Alzheimer's disease. Hashimoto M; Hossain S; Katakura M; Al Mamun A; Shido O Biochim Biophys Acta; 2015 Jun; 1848(6):1402-9. PubMed ID: 25782726 [TBL] [Abstract][Full Text] [Related]
13. Docosahexaenoic acid and synaptic protection in Alzheimer's disease mice. Oster T; Pillot T Biochim Biophys Acta; 2010 Aug; 1801(8):791-8. PubMed ID: 20211757 [TBL] [Abstract][Full Text] [Related]
14. Omega-3 fatty acid docosahexaenoic acid increases SorLA/LR11, a sorting protein with reduced expression in sporadic Alzheimer's disease (AD): relevance to AD prevention. Ma QL; Teter B; Ubeda OJ; Morihara T; Dhoot D; Nyby MD; Tuck ML; Frautschy SA; Cole GM J Neurosci; 2007 Dec; 27(52):14299-307. PubMed ID: 18160637 [TBL] [Abstract][Full Text] [Related]
15. Omega-3 fatty acids enhance phagocytosis of Alzheimer's disease-related amyloid-β42 by human microglia and decrease inflammatory markers. Hjorth E; Zhu M; Toro VC; Vedin I; Palmblad J; Cederholm T; Freund-Levi Y; Faxen-Irving G; Wahlund LO; Basun H; Eriksdotter M; Schultzberg M J Alzheimers Dis; 2013; 35(4):697-713. PubMed ID: 23481688 [TBL] [Abstract][Full Text] [Related]
16. Human dendritic cell activities are modulated by the omega-3 fatty acid, docosahexaenoic acid, mainly through PPAR(gamma):RXR heterodimers: comparison with other polyunsaturated fatty acids. Zapata-Gonzalez F; Rueda F; Petriz J; Domingo P; Villarroya F; Diaz-Delfin J; de Madariaga MA; Domingo JC J Leukoc Biol; 2008 Oct; 84(4):1172-82. PubMed ID: 18632990 [TBL] [Abstract][Full Text] [Related]
17. Modeling Alzheimer's disease with iPSCs reveals stress phenotypes associated with intracellular Aβ and differential drug responsiveness. Kondo T; Asai M; Tsukita K; Kutoku Y; Ohsawa Y; Sunada Y; Imamura K; Egawa N; Yahata N; Okita K; Takahashi K; Asaka I; Aoi T; Watanabe A; Watanabe K; Kadoya C; Nakano R; Watanabe D; Maruyama K; Hori O; Hibino S; Choshi T; Nakahata T; Hioki H; Kaneko T; Naitoh M; Yoshikawa K; Yamawaki S; Suzuki S; Hata R; Ueno S; Seki T; Kobayashi K; Toda T; Murakami K; Irie K; Klein WL; Mori H; Asada T; Takahashi R; Iwata N; Yamanaka S; Inoue H Cell Stem Cell; 2013 Apr; 12(4):487-96. PubMed ID: 23434393 [TBL] [Abstract][Full Text] [Related]
18. Endogenous conversion of omega-6 into omega-3 fatty acids improves neuropathology in an animal model of Alzheimer's disease. Lebbadi M; Julien C; Phivilay A; Tremblay C; Emond V; Kang JX; Calon F J Alzheimers Dis; 2011; 27(4):853-69. PubMed ID: 21914946 [TBL] [Abstract][Full Text] [Related]
19. A role for docosahexaenoic acid-derived neuroprotectin D1 in neural cell survival and Alzheimer disease. Lukiw WJ; Cui JG; Marcheselli VL; Bodker M; Botkjaer A; Gotlinger K; Serhan CN; Bazan NG J Clin Invest; 2005 Oct; 115(10):2774-83. PubMed ID: 16151530 [TBL] [Abstract][Full Text] [Related]
20. Docosahexaenoic acid withstands the Aβ(25-35)-induced neurotoxicity in SH-SY5Y cells. Hashimoto M; Katakura M; Hossain S; Rahman A; Shimada T; Shido O J Nutr Biochem; 2011 Jan; 22(1):22-9. PubMed ID: 20226652 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]